Bioisosteric modifications of 2-arylureidobenzoic acids: Selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5

被引:41
作者
Valgeirsson, J
Nielsen, EO
Peters, D
Mathiesen, C
Kristensen, AS
Madsen, U
机构
[1] Danish Univ Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen, Denmark
[2] Danish Univ Pharmaceut Sci, Dept Pharmacol, DK-2100 Copenhagen, Denmark
[3] NeuroSearch AS, DK-2750 Ballerup, Denmark
关键词
D O I
10.1021/jm030638w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
2-Arylureidobenzoic acids (AUBAs) have recently been presented as the first series of selective noncompetitive GluR5 antagonists. In this paper we have modified the acidic moiety of the AUBAs by introducing different acidic and neutral groups, and similarly, we have replaced the urea linker of the AUBAs with other structurally related linkers. Replacing the acid with neutral substituents led to inactive compounds in all instances, showing that an acidic moiety is necessary for activity. Replacing the carboxylic moiety in 2a with a sulfonic acid (5c) or a tetrazole ring (5d) improved the potency at GluR5 receptors (compounds 5c and 5d showed IC50 values of 1.5 and 2.0 muM, respectively, compared to compound 2a with IC50 = 4.8 muM). Compound 5c did not show improved in vivo activity in the ATPA rigidity test compared to 2a, whereas compound 5d was 4 times more potent than 2a. All compounds wherein the urea linker had been replaced showed lower or no activity. The results described extend the knowledge of structure-activity relationships for the AUBAs, and compound 5d may prove to be a good candidate for studying GluR5 receptors in vitro and in vivo.
引用
收藏
页码:6948 / 6957
页数:10
相关论文
共 34 条
[1]   Highly satisfactory procedures for the Pd-catalyzed cross coupling of aryl electrophiles with in situ generated alkynylzinc derivatives [J].
Anastasia, L ;
Negishi, E .
ORGANIC LETTERS, 2001, 3 (20) :3111-3113
[2]   Ligands for glutamate receptors:: Design and therapeutic prospects [J].
Bräuner-Osborne, H ;
Egebjerg, J ;
Nielsen, EO ;
Madsen, U ;
Krogsgaard-Larsen, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2609-2645
[3]   Synthesis and receptor binding affinity of new selective GluR5 ligands [J].
Bunch, L ;
Johansen, TH ;
Bräuner-Osborne, H ;
Stensbol, TB ;
Johansen, TN ;
Krogsgaard-Larsen, P ;
Madsen, U .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (04) :875-879
[4]   3-NITRO-3,4-DIHYDRO-2(1H)-QUINOLONES - EXCITATORY AMINO-ACID ANTAGONISTS ACTING AT GLYCINE-SITE NMDA AND (RS)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTORS [J].
CARLING, RW ;
LEESON, PD ;
MOORE, KW ;
SMITH, JD ;
MOYES, CR ;
MAWER, IM ;
THOMAS, S ;
CHAN, T ;
BAKER, R ;
FOSTER, AC ;
GRIMWOOD, S ;
KEMP, JA ;
MARSHALL, GR ;
TRICKLEBANK, MD ;
SAYWELL, KL .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (22) :3397-3408
[5]   A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission [J].
Clarke, VRJ ;
Ballyk, BA ;
Hoo, KH ;
Mandelzys, A ;
Pellizzari, A ;
Bath, CP ;
Thomas, J ;
Sharpe, EF ;
Davies, CH ;
Ornstein, PL ;
Schoepp, DD ;
Kamboj, RK ;
Collingridge, GL ;
Lodge, D ;
Bleakman, D .
NATURE, 1997, 389 (6651) :599-603
[6]  
DAN FM, 1972, J CHEM SOC P1, V16, P2007
[7]  
Di Fabio R, 2000, CAN J CHEM, V78, P809
[8]  
Dingledine R, 1999, PHARMACOL REV, V51, P7
[9]   Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycarbonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester:: A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine [J].
Filla, SA ;
Winter, MA ;
Johnson, KW ;
Bleakman, D ;
Bell, MG ;
Bleisch, TJ ;
Castaño, AM ;
Clemens-Smith, A ;
del Prado, M ;
Dieckman, DK ;
Dominguez, E ;
Escribano, A ;
Ho, KH ;
Hudziak, KJ ;
Katofiasc, MA ;
Martinez-Perez, JA ;
Mateo, A ;
Mathes, BM ;
Mattiuz, EL ;
Ogden, AML ;
Phebus, LA ;
Stack, DR ;
Stratford, RE ;
Ornstein, PL .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (20) :4383-4386
[10]  
Gabriele B, 2001, EUR J ORG CHEM, V2001, P4607